Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex

Journal of Neuroimmunology

Volumn 48, Issue 1, 1993, Pages 59-69

  Sun, Lei ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; PHORBOL ESTER; T LYMPHOCYTE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYCLIC AMP; FEMALE; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0027432475     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(93)90059-8     Document Type: Article

References (52)

1. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels
2. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts
3. Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration
4. Inhibition of mouse T cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis
5. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells
6. IL 2, 4 and 5 are sequentially produced in mitogen-stimulated murine spleen cell cultures
7. Distribution of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine
8. Single step method of isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Specific binding sites for vasoactive intestinal peptide on nonadherent peripheral blood lymphocytes
10. Inhibition of cytokine production by cyclosporin A and transforming growth factor β
11. Noradrenergic and peptidergic innervation of lymphoid tissue
12. High-affinity receptors for VIP on human myeloma cells
13. Multiple neuropeptdes in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neurotransmission
14. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
15. Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes
16. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus
17. Occurrence of vasoactive intestinal peptide (VIP) in lymphoid organs from rat and mouse
18. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells
19. Interaction of vasoactive intestinal peptide with human blood mononuclear cells
20. Human T cell activation. Monocyte-independent activation and proliferation induced by a T3 monoclonal antibody in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13-acetate
21. Heterogeneity of helper/inducer T lymphocytes. Lymphokine production and lymphokine responsiveness
22. Identification of a monoclonal antibody specific for a murine T3 polypeptide
23. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection
24. Differential regulation by phorbol myristate acetate of IFNγ and IL-4 expression in anti-CD3 stimulated mouse spleen cells
25. Modification of lymphocyte traffic by vasoactive neurotransmitter substances
26. Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP)
27. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxocity assays
28. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins
29. The neuroimmune link in the bronchus-associated lymphoid tissue (BALT) of cat and rat: peptides and neural markers
30. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
31. Vasoactive intestinal polypeptide stimulation of adenylate cyclase in purified human leukocuytes
32. Cyclic AMP-dependent protein kinase in MOLT 4B lymphoblasts: identification by photoaffinity labelling and activation in intact cells by vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI)
33. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage
34. In vitro alterations of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells
35. Evidence for local neuromodulation of T cell migration in vivo
36. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
37. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen response
38. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells
39. Vasoactive intestinal peptide-containing nerves in Peyer's patches
40. Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies
41. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptide and β-adrenergic agonist in murine T-cell lymphomas of immature, helper, and cytotoxic types
42. Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide
43. CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal peptide
44. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages
45. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen
46. An improved colorimetric assay for interleukin 2
47. T cell activation through TCR/CD3 complex. IL-2 production of T cell clones stimulated with anti-CD3 without cross-linkage
48. Inhibition of anti-CD3-induced T cell proliferation by crosslinking of stimulatory antibodies in the presence of PMA and interleukin 2
49. Functional studies with CD3 heavy-chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of IL-2 responsiveness in T cells by ϵ-anti-CD3
50. Vasoactive intestinal peptide Messenger in a neuroimmune axis
51. Binding of vasoactive intestinal peptide (VIP) by human blood monocytes: demonstration of specific binding sites
52. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts